Pharmaceutical Technology's In the Lab eNewsletter
This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.
Shoreh Shabrang
Advertisement
Shoreh Shabrang is senior consultant RA CMC, SAABAS LLC.
Articles by Shoreh Shabrang
The authors support the retiring of Ph. Eur. and USP heavy metal assays and propose a means of updating related specifications with minimal regulatory burden.
Advertisement
Latest Updated Articles
Pharma Collaboration Proposes Retirement of Obsolete Heavy Metals TestsSeptember 1st 2018
- Retirement for Obsolete Heavy Metals Tests
October 3rd 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5